Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Michael Joner Added: 2 months ago
In this interview, Prof Michael Joner (German Heart Centre, Munich, DE) discusses the specific needs and treatment considerations when managing low and intermediate risk TAVI patients. He also highlights the increasing need to consider future interventions when selecting the index valve.Prof Joner details the Navitor TAVI system resheathable design with intra-annular function, large-cell frame… View more
Author(s): , Added: 2 years ago
In this series of short interviews and discussions filmed at AV Valves Summit 2023, the faculty delve into sharing invaluable insights and expert opinion on transcathetermitral and tricuspid intervention. They examine a range of topics which include the development of TEER, the importance of quality of life, repair vs replacement and how to best shape the future of MR and TR treatment. The AV… View more
Added: 1 week ago Source:  Radcliffe Cardiology
An exploratory analysis of the EARLY TAVR trial has found that the benefits of early transcatheter aortic valve replacement (TAVR) for asymptomatic severe aortic stenosis (AS) are consistent, regardless of baseline left ventricular (LV) health.¹ This suggests that waiting for LV deterioration may not be the optimal strategy for timing intervention.MethodologyThis analysis used data from the EARLY… View more
Research Area(s) / Expertise: Job title: Chairman of the Department of Clinical Medicine and Prevention
Giuseppe Mancia is an Italian physician and scientist internationally recognized for his lifelong contributions to cardiovascular medicine and hypertension research. He has spent the majority of his academic and clinical career in Milan and Monza, Italy, where he has played a central role in shaping modern hypertension research, education, and clinical practice across Europe and worldwide… View more
Research Area(s) / Expertise: Job title: Professor of Interventional Medicine
Professor Patrick W. Serruys was born in Belgium in 1947. He completed his medical degree (M.D.) at the University of Leuven in 1972 and initially pursued research in muscle physiology before moving into cardiology, setting the stage for a lifelong career in interventional cardiovascular medicineProf Patrick W. Serruys is widely regarded as one of the most influential interventional cardiologists… View more
Author(s): Rania Hammami , Uthman Aluthman Added: 9 months ago
TCT Middle East 2025 — We are joined by Prof Rania Hammami and Dr Uthman Aluthman as they discuss the key takeaways for minimally invasive surgery from the conference.The specialists provide insights on evolving definitions and expanding applications of minimally invasive cardiac surgical techniques. They address practical considerations regarding patient selection, recovery trajectories, and… View more
Author(s): Davide Capodanno , Sneha Shah Jain Added: 6 months ago
Presented at the European Society of Cardiology (ESC) Congress 2025, Prof Carolyn Lam (Singapore, UK), Prof Davide Capodanno (Catania, IT), Dr Sneha Shah Jain (Stanford, US) and Prof Jeffrey Weitz (Hamilton, CA) examine the prevalence and challenges of stroke prevention in atrial fibrillation (AF) and after acute coronary syndrome (ACS). The faculty review current treatment guidelines, explore… View more
Author(s): Mirvat Alasnag , Khaled Al-Shaibi Added: 6 months ago
ESC Congress 2025 – Day 3 of ESC Congress 2025 continued to deliver groundbreaking research with pivotal studies shaping the future of cardiovascular medicine.Interventional cardiologists Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (King Fahd Armed Forces Hospital, SA) provide their comprehensive breakdown of the most impactful hot line trial results from the day's sessions.Day 3 Highlights… View more